Victoria Vakiener, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 8,340 shares at $37.87 ($317K) on 2024-01-11, disclosed to the SEC on 2024-01-16.
Scheduled sale ($317k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.87 | 3,620 | $137K | 43.3% |
| 2 | $37.87 | 3,620 | $137K | 43.3% |
| 3 | $38.84 | 1,100 | $43K | 13.5% |
| Total | $38.00 avg | 8,340 | $317K | 100% |
| Filing → |
| ARWR | SELL | 2024-05-06 | $42K | — | Filing → |
| ARWR | SELL | 2023-10-02 | $41K | — | Filing → |
| EPZM | SELL | 2021-02-05 | $9K | — | Filing → |